Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers
Conclusion: This preventive program avoided any COVID-19 infection among patients and HCWs, so that an elective breast cancer surgical procedure can be safely and timely pursued without affecting the oncologic outcome.
Source: In Vivo - Category: Research Authors: FREGATTI, P., GIPPONI, M., GIACCHINO, M., SPARAVIGNA, M., DIAZ, R., FIORAVANTI, E., CORNACCHIA, C., CONTE, B., LAMBERTINI, M., ZOPPOLI, G., MURELLI, F., TONI, M. L., CALABRO, M. T., ORSINO, L., FRIEDMAN, D. Tags: Articles on Covid-19 Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | COVID-19 | Health Management | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nurses | Nursing | Pandemics | Research | SARS